Mirtazapine
Product Images NDC 67046-479

2 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 67046-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine Chemical Structure (D423d909 F428 4514 9814 E0a6b94de27a 01)

Mirtazapine Chemical Structure (D423d909 F428 4514 9814 E0a6b94de27a 01)
Chemical structure diagram of mirtazapine, depicting its multiple cyclic rings including a methyl group attached to a nitrogen atom in a piperazine ring system.*
FDA Label Image

15 mg X 100 Tablets (D423d909 F428 4514 9814 E0a6b94de27a 02)

15 mg X 100 Tablets (D423d909 F428 4514 9814 E0a6b94de27a 02)
Label for mirtazapine 15 mg tablets, package of 30 tablets, labeled Rx only. Includes lot number DF6195, expiration date 04/24/15, and pill ID E20. Manufactured by Sandoz and packaged by Contract Pharmacy Services-PA, Warrington, PA. Storage instructions specify 20°-25°C (68°-77°F). The label states each tablet contains 15 mg mirtazapine and advises to see accompanying literature for dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.